Viewing Study NCT06762769


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2025-12-31 @ 1:19 AM
Study NCT ID: NCT06762769
Status: RECRUITING
Last Update Posted: 2025-08-01
First Post: 2024-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Sponsor: University College, London
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module